share_log

先施(00244)发布中期业绩 股东应占亏损2726万港元 同比扩大55.83%

The company Sinopharm (00244) released its interim results, with a shareholder's attributable loss of 27.26 million Hong Kong dollars, a year-on-year increase of 55.83%.

Zhitong Finance ·  Aug 28 10:21

Sa Sa (00244) released its mid-term business performance for 2024, with a revenue of HKD 65.05 million, a year-on-year decrease...

According to the announcement, Sa Sa (00244) released its mid-term business performance for 2024, with a revenue of HKD 65.05 million, a year-on-year decrease of 12.52%. Shareholders' loss amounted to HKD 27.26 million, a year-on-year expansion of 55.83%. The basic loss per share was HKD 0.02.

The announcement stated that in the first half of 2024, the group's department store business achieved a revenue of approximately HKD 65.3 million (compared to approximately HKD 74.3 million in the first half of 2023), a decrease of approximately 12.1% from the first half of 2023. This is mainly due to weak consumer spending and a generally low market sentiment in the retail trade in the first half of 2024.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment